Search research articles
Contact Us
Filters
Showing results (181-190 of 228) with videos related to
Page
of 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 2020
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer
Anna S Berghoff, Christoph Wippel, Angelika M Starzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy
Peter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
Journal of Psychosomatic Research
|
December 17, 2024
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients
Elisabeth L Zeilinger, Matthias Knefel, Andreas Erfurth, et al.
International Journal of Clinical and Health Psychology : IJCHP
|
September 4, 2023
The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients
Elisabeth Lucia Zeilinger, Matthias Knefel, Carmen Schneckenreiter, et al.
Future Oncology (London, England)
|
February 28, 2025
TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases
Maximilian Marhold, Marta Vaz Batista, Isabel Blancas, et al.
JCO Global Oncology
|
February 2, 2021
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology
Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, et al.
Journal of Translational Medicine
|
October 8, 2024
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine
Viktoria Knöbl, Lukas Maier, Stefan Grasl, et al.
ESMO Open
|
October 14, 2020
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
Maximilian Marhold, Thais Topakian, Hermine Agis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer
Christian F Singer, Yen Y Tan, Florian Fitzal, et al.
The Lancet. Oncology
|
February 16, 2019
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial
Sherene Loi, Anita Giobbie-Hurder, Andrea Gombos, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 228) with videos related to
Sort By:
Page
of 23
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 2020
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer
Anna S Berghoff, Christoph Wippel, Angelika M Starzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy
Peter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
Journal of Psychosomatic Research
|
December 17, 2024
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients
Elisabeth L Zeilinger, Matthias Knefel, Andreas Erfurth, et al.
International Journal of Clinical and Health Psychology : IJCHP
|
September 4, 2023
The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients
Elisabeth Lucia Zeilinger, Matthias Knefel, Carmen Schneckenreiter, et al.
Future Oncology (London, England)
|
February 28, 2025
TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases
Maximilian Marhold, Marta Vaz Batista, Isabel Blancas, et al.
JCO Global Oncology
|
February 2, 2021
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology
Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, et al.
Journal of Translational Medicine
|
October 8, 2024
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine
Viktoria Knöbl, Lukas Maier, Stefan Grasl, et al.
ESMO Open
|
October 14, 2020
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
Maximilian Marhold, Thais Topakian, Hermine Agis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer
Christian F Singer, Yen Y Tan, Florian Fitzal, et al.
The Lancet. Oncology
|
February 16, 2019
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial
Sherene Loi, Anita Giobbie-Hurder, Andrea Gombos, et al.
Page
of 23